NeoGenomics, Inc. Payments for Restructuring
NeoGenomics, Inc. (NEO) reported Payments for Restructuring of $2.49 million for the 3-month period ending 2023-09-30, per its 10-Q filed 2023-11-06.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsForRestructuring · last filed 2023-11-06
- NeoGenomics, Inc. payments for restructuring for the quarter ending 2023-09-30 was $2.49M.
- NeoGenomics, Inc. payments for restructuring for the quarter ending 2023-06-30 was $2.95M.
- NeoGenomics, Inc. payments for restructuring for the quarter ending 2023-03-31 was $2.19M.
- NeoGenomics, Inc. payments for restructuring for fiscal 2022 was $3.00M.
| Period end | Payments for Restructuring 3 month | Payments for Restructuring 6 month | Payments for Restructuring 9 month | Payments for Restructuring 12 month |
|---|---|---|---|---|
| 2023-09-30 | $2.49M 10-Q · filed 2023-11-06 | $5.44M derived: sum of 2 quarters · filed 2023-11-06 | $7.63M derived: sum of 3 quarters · filed 2023-11-06 | |
| 2023-06-30 | $2.95M 10-Q · filed 2023-11-06 | $5.14M derived: sum of 2 quarters · filed 2023-11-06 | ||
| 2023-03-31 | $2.19M 10-Q · filed 2023-11-06 | |||
| 2022-12-31 | $3.00M 10-K · filed 2023-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 20/20 Biolabs, Inc. (AIDX) | United States | $0.005B |